Leisure and Lifestyle News / Equigerminal SA PT509756638

Equigerminal Team Launches Indiegogo Campaign to Counter New Equine Virus

Via: ReleaseWire

Updated 9:15 AM CDT, Fri, July 13,2018

Now Seeking Community Support via Indiegogo, New Equine Virus or NEV is Similar to HIV & is a Serious Threat to the Horse Population Worldwide!

Coimbra, Portugal -- (ReleaseWire) -- 07/13/2018 -- New Equine Virus or NEV is a horse equivalent of HIV and is becoming an increasingly serious threat to at least 10 percent of the global horse population. To counter this emerging threat, Equigerminal Team has launched a crowdfunding campaign to raise funds and support for the development of tests and antivirals to control this threat. The team of scientists is now welcoming everyone to generously support this fundraising campaign and their goal is to raise a sum of EUR 15,000.

"Our biggest achievement to date is the discovery of a new virus that affects horses, which we are calling NEV." Said the spokesperson of Equigerminal Team, while introducing this campaign to the Indiegogo community. "This virus is essentially the horse equivalent of HIV, and it could be present in as much as 10% of the horse population." She added. Equigerminal is a horse biotech company that has been setup to find and cure newly identified diseases.

The Indiegogo Campaign is located on the web at: www.indiegogo.com/projects/equigerminal-pets and supporters from around the world can back this project by making generous pledges and donations. Everyone, especially pet lovers and those who care about saving a major chunk of horse population are welcomed to participate in the fundraising. The team is offering NEV tests as a reward for the backers and more details are available on the Indiegogo campaign page of the project.

About Equigerminal
Equigerminal is a horse biotech company based in Europe and it has recently discovered a new lentivirus that affects horses. The new virus is called New Equine Virus (NEV) and it is a serious threat to the horse population worldwide. The team of scientists is now raising funds and support to counter this threat via Indiegogo and it is welcoming everyone for generous community backing.

Contact Person: Isabel Carvalho
Company: Equigerminal SA PT509756638
City: Coimbra
State: Coimbra
Country: Portugal
Phone: +351 239094666
Email: isabel@equigerminal.pt
Website: www.indiegogo.com/projects/equigerminal-pets

For more information on this press release visit:

Media Relations Contact
Isabel Carvalho
Email: Click to Email Isabel Carvalho
Web: http://www.indiegogo.com/projects/equigerminal-pets